CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 13 enrolled
Drug / intervention
Cellulose Powder +3 moredietary
Likely dose
Caffeine 3 mg/kg Oral Powderfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07090421
NCT07090421N/ACompleted

Varying Doses of Evening Caffeine Ingestion Have Different Effects on Rowing Ergometer Performance, Sleep Quality and Wakefulness Scores

Ulaç Can YILDIRIM·interventional·Posted Jul 29, 2025·Updated Jul 29, 2025

In Brief

A clinical study evaluating Cellulose Powder, Caffeine 3 mg/kg Oral Powder, and 2 other interventions for Healthy Volunteers and 2 related conditions. Completed, enrolled 13 participants across 1 site.

Detailed Summary

The goal of this clinical trial is to learn how different doses of caffeine taken in the evening affect rowing performance, sleep quality, and daytime alertness in trained male university rowers. The main questions it aims to answer are: Does a low, moderate, or high caffeine dose improve rowing performance? How do these doses affect sleep and recovery after evening exercise? Participants completed four rowing tests after consuming either a placebo, low (3 mg/kg), moderate (6 mg/kg), or high (9 mg/kg) dose of caffeine. Researchers measured rowing time, power, heart rate, sleep quality, and daytime sleepiness. The study found that moderate and high caffeine doses improved rowing performance the most. However, these same doses made it harder for participants to sleep well and feel alert the next day. Headaches and stomach issues were also more common with the high dose. The low dose gave smaller performance gains but caused fewer side effects. This study shows that evening caffeine can boost performance but may hurt recovery and sleep. Athletes and coaches should weigh these trade-offs when using caffeine for late-day training or competition.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesTurkey (Türkiye)
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedJul 29, 2025
Enrollment StartJul 24, 2022
Primary CompletionAug 24, 2022
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 11 months ago

Interventions

Cellulose Powderdietary

Participants consumed an inert cellulose powder dissolved in water, containing no active caffeine. The placebo was ingested orally 60 minutes prior to the rowing performance test. This condition served as the control and was administered once per session in a randomized, double-blind, crossover design.

Caffeine 3 mg/kg Oral Powderdietary

Participants consumed caffeine in powder form at a dose of 3 milligrams per kilogram of body weight. The powder was dissolved in water and ingested orally approximately 60 minutes before the start of the 2000-meter rowing ergometer performance test. The intervention was administered once per session in a randomized, double-blind, crossover design.

Caffeine 6 mg/kg Oral Powderdietary

Participants ingested caffeine in powder form, dissolved in water, at a dose of 6 milligrams per kilogram of body mass. The solution was consumed orally 60 minutes prior to the 2000-meter rowing performance test. This intervention was administered once per session as part of a randomized, double-blind, crossover design.

Caffeine 9 mg/kg Oral Powderdietary

A powdered caffeine dose of 9 milligrams per kilogram was dissolved in water and consumed orally by participants 60 minutes before a 2000-meter rowing ergometer trial. The intervention was administered once per session under a randomized, double-blind, crossover design.